Maxim De Schaepdryver

ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 7

Top Venues

Journal of neurology, neurosurgery, and psychiatry

Annals of clinical and translational neurology

Nature medicine

Clinical chemistry and laboratory medicine

KU Leuven

This page only lists publications with an associated author ORCID identifier.

Affiliation History

KU Leuven Nov 01 2016

Belgium

PhD student :: Department of Neurosciences, Laboratory for Molecular Neurobiomarker Research

Publications

Maxim De Schaepdryver, Pegah Masrori, Philip Van Damme, Koen Poesen
Effect of neurofilament analysis on the diagnostic delay in amyotrophic lateral sclerosis. CNS neuroscience & therapeutics (2022)
Bram De Wel, Maxim De Schaepdryver, Koen Poesen, Kristl G Claeys
Biochemical and clinical biomarkers in adult SMA 3-4 patients treated with nusinersen for 22 months. Annals of clinical and translational neurology 9 (8) (2022)
Anna Månberg, Nathan Skene, Folkert Sanders, Marta Trusohamn, Julia Remnestål, Anna Szczepińska, Inci Sevval Aksoylu, Peter Lönnerberg, Lwaki Ebarasi, Stefan Wouters, Manuela Lehmann, Jennie Olofsson, Inti von Gohren Antequera, Aylin Domaniku, Maxim De Schaepdryver, Joke De Vocht, Koen Poesen, Mathias Uhlen, Jasper Anink, Caroline Mijnsbergen, Hermieneke Vergunst-Bosch, Annemarie Hübers, Ulf Kläppe, Elena Rodriguez-Vieitez, Jonathan D Gilthorpe, Eva Hedlund, Robert A Harris, Eleonora Aronica, Philip Van Damme, Albert Ludolph, Jan Herman Veldink, Caroline Ingre, Peter Nilsson, Sebastian A Lewandowski
Altered perivascular fibroblast activity precedes ALS disease onset. Nature medicine 27 (4) (2021)
Pegah Masrori, Maxim De Schaepdryver, Mary Kay Floeter, Joke De Vocht, Nikita Lamaire, Ann D'Hondt, Bryan Traynor, Koen Poesen, Philip Van Damme
Prognostic relationship of neurofilaments, CHIT1, YKL-40 and MCP-1 in amyotrophic lateral sclerosis. Journal of neurology, neurosurgery, and psychiatry 93 (6) (2021)
Maxim De Schaepdryver, Janne Goossens, Andreas Jeromin, Britta Brix, Philip Van Damme, Koen Poesen
Analytical performance of a CE-marked immunoassay to quantify phosphorylated neurofilament heavy chains. Clinical chemistry and laboratory medicine 57 (8) (2020)
Maxim De Schaepdryver, Christian Lunetta, Claudia Tarlarini, Lorena Mosca, Adriano Chio, Philip Van Damme, Koen Poesen
Neurofilament light chain and C reactive protein explored as predictors of survival in amyotrophic lateral sclerosis. Journal of neurology, neurosurgery, and psychiatry 91 (4) (2020)
Maxim De Schaepdryver, Janne Goossens, Steffi De Meyer, Andreas Jeromin, Pegah Masrori, Britta Brix, Kristl G Claeys, Jolien Schaeverbeke, Katarzyna Adamczuk, Rik Vandenberghe, Philip Van Damme, Koen Poesen
Serum neurofilament heavy chains as early marker of motor neuron degeneration. Annals of clinical and translational neurology 6 (10) (2019)

Maxim De Schaepdryver.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Maxim De Schaepdryver